Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration

References

• Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–e116. doi:10.1016/S2214-109X(13)70145-1
   PubMed Web of Science ®Google Scholar
• Yonekawa Y, Kim IK. Clinical characteristics and current treatment of age-related macular degeneration. Cold Spring Harb Perspect Med. 2015;5(1):a017178. doi:10.1101/cshperspect.a017178
   Web of Science ®Google Scholar
• Schwartz SG, Hampton BM, Kovach JL, Brantley MA. Genetics and age-related macular degeneration: a practical review for the clinician. Clin Ophthalmol. 2016;10:1229–1235. doi:10.2147/OPTH.S109723
   Google Scholar
• Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385–389. doi:10.1126/science.1109557
   PubMed Web of Science ®Google Scholar
• Fritsche LG, Igl W, Bailey JNC, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134–143. doi:10.1038/ng.3448
   PubMed Web of Science ®Google Scholar
• Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu Rev Genom Hum Genet. 2014;15(1):151–171. doi:10.1146/annurev-genom-090413-025610
   PubMed Web of Science ®Google Scholar
• Parmeggiani F, Sorrentino FS, Romano MR, et al. Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators Inflamm. 2013;2013:1–13. doi:10.1155/2013/435607
   Web of Science ®Google Scholar
• Bonyadi MHJ, Yaseri M, Soheilian M. Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis. Ophthalmic Genet. 2020;1–7. doi:10.1080/13816810.2020.1765396
   Web of Science ®Google Scholar
• Bonyadi MHJ, Yaseri M, Nikkhah H, Bonyadi M, Soheilian M. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis. Acta Ophthalmol. 2018;96(2):e105–e110. doi:10.1111/aos.13494
   Web of Science ®Google Scholar
• Kanda A, Chen W, Othman M, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A. 2007;104(41):16227–16232. doi:10.1073/pnas.0703933104
   PubMed Web of Science ®Google Scholar
• Wang G, Spencer KL, Court BL, et al. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Invest Ophthalmol Vis Sci. 2009;50(7):3084–3090. doi:10.1167/iovs.08-3240
   PubMed Web of Science ®Google Scholar
• Grassmann F, Heid IM, Weber BHF. Recombinant haplotypes narrow the ARMS2/HTRA1 association signal for age-related macular degeneration. Genetics. 2017;205(2):919–924. doi:10.1534/genetics.116.195966
   PubMed Web of Science ®Google Scholar
• Hadley D, Orlin A, Brown G, et al. Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. Invest Ophthalmol Vis Sci. 2010;51(4):2191–2196. doi:10.1167/iovs.09-3798
   Web of Science ®Google Scholar
• Ricci F, Zampatti S, D’Abbruzzi F, et al. Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population. Arch Ophthalmol. 2009;127(10):1368–1372. doi:10.1001/archophthalmol.2009.237
   PubMedGoogle Scholar
• Gotoh N, Nakanishi H, Hayashi H, et al. ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Am J Ophthalmol. 2009;147(6):1037–1041.e2. doi:10.1016/j.ajo.2008.12.036
   PubMed Web of Science ®Google Scholar
• Fritsche LG, Loenhardt T, Janssen A, et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet. 2008;40(7):892–896. doi:10.1038/ng.170
   PubMed Web of Science ®Google Scholar
• Iejima D, Itabashi T, Kawamura Y, et al. HTRA1 (high temperature requirement a serine peptidase 1) gene is transcriptionally regulated by insertion/deletion nucleotides located at the 3′ end of the ARMS2 (age-related maculopathy susceptibility 2) gene in patients with age-related macular degeneration. J Biol Chem. 2015;290(5):2784–2797. doi:10.1074/jbc.M114.593384
   Web of Science ®Google Scholar
• Vavvas DG, Small KW, Awh CC, Zanke BW, Tibshirani RJ, Kustra R. CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation. Proc Natl Acad Sci USA. 2018;115(4):E696–E704. doi:10.1073/pnas.1718059115
   Web of Science ®Google Scholar
• Lechanteur YTE, van de Camp PL, Smailhodzic D, et al. Association of smoking and CFH and ARMS2 risk variants with younger age at onset of neovascular age-related macular degeneration. JAMA Ophthalmol. 2015;133(5):533–541. doi:10.1001/jamaophthalmol.2015.18
   Web of Science ®Google Scholar
• Smailhodzic D, Klaver CCW, Klevering BJ, et al. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology. 2012;119(2):339–346. doi:10.1016/j.ophtha.2011.07.056
   PubMed Web of Science ®Google Scholar
• Brión M, Sanchez‐Salorio M, Cortón M, et al. Genetic association study of age-related macular degeneration in the Spanish population. Acta Ophthalmol. 2011;89(1):e12–e22. doi:10.1111/j.1755-3768.2010.02040.x
   Web of Science ®Google Scholar
• Wang G, Spencer KL, Scott WK, et al. Analysis of the indel at the ARMS2 3′UTR in age-related macular degeneration. Hum Genet. 2010;127(5):595–602. doi:10.1007/s00439-010-0805-8
   PubMed Web of Science ®Google Scholar
• Zysset-Burri DC, Keller I, Berger LE, et al. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med. 2020;5(1):1–11. doi:10.1038/s41525-020-00141-0
   PubMed Web of Science ®Google Scholar
• Sundaresan P, Vashist P, Ravindran RD, et al. Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study. Invest Ophthalmol Vis Sci. 2012;53(12):7492. doi:10.1167/iovs.12-10073
   Web of Science ®Google Scholar
• Yasuma TR, Nakamura M, Nishiguchi KM, et al. Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration. Mol Vis. 2010;16:2923.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Yamashiro K, Gotoh N, et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Invest Ophthalmol Vis Sci. 2010;51(11):5914–5919. doi:10.1167/iovs.10-5554
   Web of Science ®Google Scholar
• Zhuang W, Li H, Liu Y, et al. Association of specific genetic polymorphisms with age-related macular degeneration in a Northern Chinese population. Ophthalmic Genet. 2014;35(3):156–161. doi:10.3109/13816810.2014.921314
   PubMed Web of Science ®Google Scholar
• Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39(5):367–374. doi:10.1016/S0039-6257(05)80092-X
   PubMed Web of Science ®Google Scholar
• Ferris FL, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844–851. doi:10.1016/j.ophtha.2012.10.036
   PubMed Web of Science ®Google Scholar
• Ruamviboonsuk P, Tadarati M, Singhanetr P, et al. Genome-wide association study of neovascular age-related macular degeneration in the Thai population. J Hum Genet. 2017;62(11):957–962. doi:10.1038/jhg.2017.72
   Web of Science ®Google Scholar
• Cheung CMG, Laude A, Yeo I, et al. Systemic, ocular and genetic risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Singaporeans. Sci Rep. 2017;7. doi:10.1038/srep41386
   Web of Science ®Google Scholar
• Rajendran A, Dhoble P, Sundaresan P, et al. Genetic risk factors for late age-related macular degeneration in India. Br J Ophthalmol. 2018;102(9):1213–1217. doi:10.1136/bjophthalmol-2017-311384
   PubMed Web of Science ®Google Scholar
• Mohamad NA, Ramachandran V, Mohd Isa H, et al. Association of HTRA1 and ARMS2 gene polymorphisms with response to intravitreal ranibizumab among neovascular age-related macular degenerative subjects. Hum Genomics. 2019;13. doi:10.1186/s40246-019-0197-3
   Web of Science ®Google Scholar
• Xu Y, Guan N, Xu J, et al. Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population. Mol Vis. 2008;14:1373.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Huang L, Li X, Zhou P, Zeng W, Zhang C. Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy. Lee H-C, ed. PLoS One. 2013;8(1):e53665. doi:10.1371/journal.pone.0053665
   Web of Science ®Google Scholar
• Yanagisawa S, Kondo N, Miki A, et al. Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2). Mol Vis. 2011;17:3574–3582.
   Web of Science ®Google Scholar
• Aoki A, Tan X, Yamagishi R, et al. Risk factors for age-related macular degeneration in an elderly Japanese population: the Hatoyama Study. Invest Ophthalmol Vis Sci. 2015;56(4):2580–2585. doi:10.1167/iovs.14-16339
   PubMed Web of Science ®Google Scholar
• Lee SJ, Kim NR, Chin HS. LOC387715/HTRA1 polymorphisms, smoking and combined effects on exudative age-related macular degeneration in a Korean population. Clin Experiment Ophthalmol. 2010;38(7):698–704. doi:10.1111/j.1442-9071.2010.02316.x
   Web of Science ®Google Scholar
• Chakravarthy U, McKay GJ, de Jong PTVM, et al. ARMS2 increases the risk of early and late age-related macular degeneration in the European eye study. Ophthalmology. 2013;120(2):342–348. doi:10.1016/j.ophtha.2012.08.004
   PubMed Web of Science ®Google Scholar
• Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Nazari R, Soheilian M. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis. Int Ophthalmol. 2019;39(4):949–956. doi:10.1007/s10792-018-0853-y
   Web of Science ®Google Scholar
• Kaur I, Cantsilieris S, Katta S, et al. Association of the del443ins54 at the ARMS2 locus in Indian and Australian cohorts with age-related macular degeneration. Mol Vis. 2013;19:822–828.
   PubMed Web of Science ®Google Scholar
• Restrepo NA, Spencer KL, Goodloe R, et al. Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study. Invest Ophthalmol Vis Sci. 2014;55(10):6839–6850. doi:10.1167/iovs.14-14246
   PubMed Web of Science ®Google Scholar
• Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H, Lotery AJ. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Eye. 2007;22(6):849–854. doi:10.1038/sj.eye.6702830
   Web of Science ®Google Scholar
• Matušková V, Zeman T, Ewerlingová L, et al. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population. Acta Ophthalmol. 2020;98:e691–e699. doi:10.1111/aos.14357
   Web of Science ®Google Scholar
• Gotoh N, Yamada R, Hiratani H, et al. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum Genet. 2006;120(1):139–143. doi:10.1007/s00439-006-0187-0
   PubMed Web of Science ®Google Scholar
• Okamoto H, Umeda S, Obazawa M, et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol Vis. 2006;12:156–158.
   PubMed Web of Science ®Google Scholar
• Uka J, Tamura H, Kobayashi T, et al. No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population. Retina. 2006;26(9):985–987. doi:10.1097/01.iae.0000244068.18520.3e
   Web of Science ®Google Scholar
• Chen LJ, Liu DTL, Tam POS, et al. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis. 2006;12:1536–1542.
   PubMed Web of Science ®Google Scholar
• Lau L-I, Chen S-J, Cheng C-Y, et al. Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci. 2006;47(8):3242. doi:10.1167/iovs.05-1532
   PubMed Web of Science ®Google Scholar
• Micklisch S, Lin Y, Jacob S, et al. Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator. J Neuroinflammation. 2017;14. doi:10.1186/s12974-016-0776-3
   Web of Science ®Google Scholar
• Yang J, Li Y, Chan L, et al. Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Hum Mol Genet. 2014;23(13):3445–3455. doi:10.1093/hmg/ddu053
   PubMed Web of Science ®Google Scholar
• Saini JS, Corneo B, Miller JD, et al. Nicotinamide ameliorates disease phenotypes in a human iPSC model of age-related macular degeneration. Cell Stem Cell. 2017;20(5):635–647.e7. doi:10.1016/j.stem.2016.12.015
   PubMed Web of Science ®Google Scholar
• Feng C, Krogh Nielsen M, Sørensen TL, Subhi Y. Systemic levels of C-reactive protein in patients with age-related macular degeneration: a systematic review with meta-analyses. Mech Ageing Dev. 2020;191:111353. doi:10.1016/j.mad.2020.111353
   Web of Science ®Google Scholar
• Hyman L, Schachat AP, He Q, Leske M. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol. 2000;118(3):351–358. doi:10.1001/archopht.118.3.351
   PubMedGoogle Scholar
• Chaikitmongkol V, Kong J, Khunsongkiet P, et al. Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol. 2019;137(6):661–667. doi:10.1001/jamaophthalmol.2019.0565
   Web of Science ®Google Scholar
• Liu R, Li J, Li Z, et al. Distinguishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina. 2016;36(4):778–786. doi:10.1097/IAE.0000000000000794
   Web of Science ®Google Scholar
• Cheung CMG, Lai TYY, Teo K, et al. Polypoidal choroidal vasculopathy: consensus nomenclature and non–indocyanine green angiograph diagnostic criteria from the Asia-pacific ocular imaging society PCV workgroup. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.08.006
   Web of Science ®Google Scholar
• Mowatt G, Hernández R, Castillo M, et al. Assessment of Diagnostic and Monitoring Studies. NIHR Journals Library; 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK263940/. Accessed July 6, 2020.
   Google Scholar
• Sandhu SS, Talks SJ. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes. Br J Ophthalmol. 2005;89(8):967–970. doi:10.1136/bjo.2004.060863
   PubMed Web of Science ®Google Scholar
• Wilde C, Patel M, Lakshmanan A, Amankwah R, Dhar-Munshi S, Amoaku W. The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography. Eye. 2015;29(5):602–610. doi:10.1038/eye.2015.44
   PubMed Web of Science ®Google Scholar